This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Relesys Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Relesys has a total shareholder equity of DKK18.3M and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK46.3M and DKK28.0M respectively.

Belangrijke informatie

Verhouding schuld/eigen vermogen

DKK 0

Schuld

Rente dekkingsratio	n/a
Contant	DKK 26.21m
Aandelen	DKK 18.28m
Totaal verplichtingen	DKK 28.03m
Totaal activa	DKK 46.31m

Recente financiële gezondheidsupdates

Companies Like Relesys (CPH:RELE) Can Afford To Invest In Growth

Jan 12

Is Relesys (CPH:RELE) In A Good Position To Invest In Growth?

Sep 15

Recent updates

Analyse van de financiële positie

Kortlopende schulden: RELE's short term assets (DKK34.1M) exceed its short term liabilities (DKK17.7M).

Langlopende schulden: RELE's short term assets (DKK34.1M) exceed its long term liabilities (DKK10.3M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RELE is debt free.

Schuld verminderen: RELE had no debt 5 years ago.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: RELE has sufficient cash runway for more than 3 years based on its current free cash flow.

Voorspelling contante baan: Insufficient data to determine if RELE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

This company listing is no longer active

Relesys Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Relesys to Delist from Nasdaq First North Growth Market Denmark

Copilot Capital Informs Relesys Regarding Intend to Cause Relesys to Request Nasdaq Copenhagen for Removal from Trading of the Shares from Nasdaq First North Growth Market

Companies Like Relesys (CPH:RELE) Can Afford To Invest In Growth

Is Relesys (CPH:RELE) In A Good Position To Invest In Growth?

Recent updates

Relesys to Delist from Nasdaq First North Growth Market Denmark

Copilot Capital Informs Relesys Regarding Intend to Cause Relesys to Request Nasdaq Copenhagen for Removal from Trading of the Shares from Nasdaq First North Growth Market

Copilot Capital Limited entered into a binding transaction agreement to acquire Relesys A/S (CPSE:RELE) from group of shareholders for DKK 380 million.

Relesys A/S to Report First Half, 2024 Results on Aug 27, 2024

Consensus EPS estimates upgraded to kr.0.32 loss

Companies Like Relesys (CPH:RELE) Can Afford To Invest In Growth

Third quarter 2023 earnings released: kr.0.03 loss per share (vs kr.0.13 loss in 3Q 2022)

Relesys A/S Provides Earnings Guidance for the Year 2023

New major risk - Revenue and earnings growth

Is Relesys (CPH:RELE) In A Good Position To Invest In Growth?

Consensus EPS estimates fall by 18%

Relesys A/S Provides Earnings Guidance for the Year 2023

High number of new and inexperienced directors

Relesys A/S Appoints Annette Blou Pryce as a Member of the Board of Directors

Relesys A/S to Report Q3, 2023 Results on Nov 29, 2023

Relesys A/S Revises Earnings Guidance for the Full Year 2022

Relesys A/S Provides Revenue Guidance for the Year 2022

Relesys A/S Revises Revenue Guidance for the Full Year of 2022

High number of new and inexperienced directors

Relesys A/S Announces Changes to the Board of Directors

Relesys A/S Provides Revenue Guidance for the Full Year of 2022

Relesys A/S Provides Revenue Guidance for the Year 2022

A Look At The Fair Value Of Relesys A/S (CPH:RELE)

High number of new and inexperienced directors

Relesys A/S, Annual General Meeting, Apr 27, 2022

Relesys A/S Provides Revenue Guidance for the Full Year of 2022

Relesys Announces Changes in Executive Management

High number of new and inexperienced directors

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven